Matthew Schwartz

Theralink Technologies, Inc. engages in the provision of biomarker assay services in the areas of oncology. The firm offers personalized medicine data through TheraLink assays to assist the biopharmaceutical industry and clinical oncologists in identifying drug treatments. It develops phosphoproteomic technologies that measure the activation status of signaling pathways. The company was founded on October 16, 2008 and is headquartered in Golden, CO.

Yale-New Haven Hospital, Inc. provides health care services and medical courses. The firm’s clinical programs and services include advanced vascular imaging services, allergy and immunology, ambulatory services, bariatric surgery program, cardiac rehabilitation, dental services, dermatology services, diabetes and endocrinology, ear, nose & throat (otolaryngology), electrophysiology and cardiac arrhythmia service and interventional cardiology. The company was founded in 1826 and is headquartered in New Haven, CT.

Comprehensive Cancer Centers of Nevada provides a range of cancer treatments, including medical oncology, hematology, radiation, breast surgery, pulmonary medicine, cancer genetic counseling, and clinical research. The private company is based in Henderson, NV. The company offers standard treatments such as chemotherapy to patients with cancer. Patients can find answers to frequently asked questions about cancer and the company on the Comprehensive Cancer Centers of Nevada FAQ page. Liawaty Ho, a medical oncologist and hematologist, treats patients at the Central Valley Treatment Center.